Current NDC auxiliary source row compounder:2200

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 72682-8264
Product Ndc: 72682-8264
Product Ndc Digits: 726828264
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Testosterone 60mg/Anastrozole 4mg Pellet
Proprietary Name Suffix: [empty]
Nonproprietary Name: Testosterone 60mg/Anastrozole 4mg Pellet
Dosage Form Name: PELLET
Route Name: SUBCUTANEOUS
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: AnazaoHealth Corporation
Establishment Name: AnazaoHealth Corporation
Establishment Fei: [empty]
Substance Name: ANASTROZOLE; TESTOSTERONE
Active Ingredients Info: 1 mg/1 mg; 1 mg/1 mg
History Active Ingredients Raw: ANASTROZOLE; TESTOSTERONE
History Active Ingredients Info Raw: 1 mg/1 mg; 1 mg/1 mg
History Dosage Raw: PELLET
Dea Schedule: CIII
Package Ndc Raw: 72682-8264-1
Package Ndc: 72682-8264-1
Package Ndc Digits: 7268282641
Package Ndc11: 72682826401
Package Description: 1 mg in 1 VIAL (72682-8264-1)
Reporting Period Raw: 2025-1
Reporting Period: 2025-1
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:2200
Source Row Number: 2200
Source Row Hash: 14131cdf673d0c73bcff574feaeda5b00e357954e1aa007de3b0f7fbfb76a202
Import Run Id: 20261024T140201Z
Loaded At: 2026-10-24 14:07:01

Exact raw FDA source fields#

{
    "ROUTENAME": "SUBCUTANEOUS",
    "PRODUCTNDC": "72682-8264",
    "DEASCHEDULE": "CIII",
    "LABELERNAME": "AnazaoHealth Corporation",
    "SUBSTANCENAME": "ANASTROZOLE; TESTOSTERONE",
    "DOSAGEFORMNAME": "PELLET",
    "NDCPACKAGECODE": "72682-8264-1",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Testosterone 60mg/Anastrozole 4mg Pellet",
    "REPORTINGPERIOD": "2025-1",
    "NONPROPRIETARYNAME": "Testosterone 60mg/Anastrozole 4mg Pellet",
    "PACKAGEDESCRIPTION": "1 mg in 1 VIAL (72682-8264-1) ",
    "ACTIVEINGREDIENTSINFO": "1 mg/1 mg; 1 mg/1 mg",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:2200
Source Row Number: 2200
Status Scope: package
Lookup Ndc: 72682-8264-1
Lookup Ndc Digits: 7268282641
Product Ndc: 72682-8264
Product Ndc Digits: 726828264
Package Ndc: 72682-8264-1
Package Ndc Digits: 7268282641
Package Ndc11: 72682826401
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2025-1
Reporting Period: 2025-1
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 14131cdf673d0c73bcff574feaeda5b00e357954e1aa007de3b0f7fbfb76a202
Import Run Id: 20261024T140201Z
Loaded At: 2026-10-24 14:07:01